RFS
JAZZ icon

Rockefeller Financial Services’s Jazz Pharmaceuticals JAZZ Stock Holding History

Rockefeller Financial Services’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-180
Closed -$29K – 529
2014
Q4 		$29K Buy
+180
New +$29.9K ﹤0.01% 408
2014
Q3 		– Sell
-3,103
Closed -$456K – 539
2014
Q2 		$456K Hold
3,103
– – 0.01% 273
2014
Q1 		$430K Sell
3,103
-1,373
-31% -$207K 0.01% 269
2013
Q4 		$566K Sell
4,476
-1,121
-20% -$116K 0.01% 260
2013
Q3 		$515K Buy
+5,597
New +$452K 0.01% 261

Other funds holding JAZZ

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
WBC
Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Rockefeller Financial Services's JAZZ Position: Q1 2015 in Review

Rockefeller Financial Services sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2015, closing a stake of 180 shares — an estimated $29K sold.

Rockefeller Financial Services first reported a position in JAZZ in Q3 2013 and held it in 5 quarters. The position peaked at $566K in Q4 2013. 354 funds tracked by Wall St. Rank hold JAZZ as of Q1 2015.

  • Rockefeller Financial Services reported no remaining Jazz Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Rockefeller Financial Services sold 180 Jazz Pharmaceuticals shares in Q1 2015, an estimated $29K.
  • Rockefeller Financial Services first reported a position in Jazz Pharmaceuticals in Q3 2013 and held it in 5 quarters.
  • Rockefeller Financial Services's Jazz Pharmaceuticals position peaked at $566K in Q4 2013.
  • 354 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2015.

Based on Rockefeller Financial Services's 13F filing for Q1 2015, filed 5 May 2015.